DUBLIN, Jan. 9, 2024 /PRNewswire/ -- The 'Global Synthetic Biology Market: Analysis By Product Type, By Technology, By Application, By End Users, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2028' report has been added to ResearchAndMarkets.com's offering.

都柏林，2024年1月9日/PRNewswire/——ResearchAndMarkets.com的报告中增加了“全球合成生物学市场：按产品类型、技术、应用、最终用户、地区、规模和趋势分析，以及对新型冠状病毒的影响和到2028年的预测”。

The global synthetic biology market was valued at US$12.97 billion in 2022, and is expected to be worth US$46.43 billion in 2028. The synthetic biology market is expected to grow at a CAGR of 23.69% over the years 2023-2028.

2022年，全球合成生物学市场价值129.7亿美元，预计2028年将达到464.3亿美元。预计2023-2028年合成生物学市场的复合年增长率将达到23.69%。

The synthetic biology market is still emerging and largely untapped. The market is expected to grow during the forecasted period. driven by advanced tools, rising research and development (R&D) coupled with heightened productivity, fueled by the integration of AI and data-driven methodologies. As products scale, the decreasing costs are anticipated to be a key driver for widespread adoption in the synthetic biology market..

合成生物学市场仍在兴起，基本上尚未开发。预计市场在预测期内会增长。在先进工具的推动下，研究与开发（R＆D）的兴起以及人工智能和数据驱动方法的集成推动了生产力的提高。随着产品规模的扩大，预计成本的下降将成为合成生物学市场广泛采用的关键驱动因素。。

The expansion is also driven from a rising number of applications within the pharmaceutical and biotechnology sector. This surge is particularly evident in the heightened demand for complex diagnostics, such as multiplexed point-of-care testing and PCR, as well as in genome editing technologies like CRISPR and vaccine development..

制药和生物技术部门的应用数量不断增加，也推动了规模的扩大。这种激增在对复杂诊断的需求增加（例如多重护理点测试和PCR）以及CRISPR和疫苗开发等基因组编辑技术中尤为明显。。

The demand is further expected to rise as demand for protein therapies and personalized medicine escalates along with research into synthetic pharmaceuticals and vaccines. Market Segmentation Analysis:

随着对蛋白质疗法和个性化药物的需求以及对合成药物和疫苗的研究不断增加，预计需求将进一步增加。市场细分分析：

By Product Type:

按产品类型：

The report identifies five segments on the basis of product type: Oligonucleotide/Oligo Pools & Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids and Chassis Organism. Oligonucleotide/Oligo Pools and Synthetic DNA segment generated the highest revenue in 2022. In several molecular and synthetic biology applications, oligonucleotides are considered the primary point..

该报告根据产品类型确定了五个部分：寡核苷酸/寡核苷酸库和合成DNA，酶，克隆技术试剂盒，异种核酸和底盘生物。2022年，寡核苷酸/寡核苷酸池和合成DNA片段产生了最高的收入。在几种分子和合成生物学应用中，寡核苷酸被认为是主要的观点。。

Increasing adoption of targeted NGS, mutagenesis experiments, DNA computing, and CRISPR gene editing are the major segment drivers for the same. For instance, OligoMix is an innovative and personalized product for genomics discoveries. It synthesizes numerous sequences of oligonucleotide in massive parallel..

越来越多地采用靶向NGS，诱变实验，DNA计算和CRISPR基因编辑是主要的细分驱动因素。例如，OligoMix是用于基因组学发现的创新和个性化产品。它大规模平行合成了许多寡核苷酸序列。。

Enzymes segment is expected to grow at the fastest CAGR during the forecasted period owing to the growing need for precise and efficient enzymatic reactions in synthetic biology applications, including gene editing and pathway optimization. Moreover, enzymes play a vital role in various industrial applications, including biofuel production and pharmaceutical manufacturing, which is further expected to propel the segment's growth.By Technology:.

由于在合成生物学应用（包括基因编辑和途径优化）中对精确有效的酶促反应的需求日益增长，预计酶段在预测期间的复合年增长率将达到最快。此外，酶在各种工业应用中发挥着至关重要的作用，包括生物燃料生产和制药制造，预计这将进一步推动该部门的增长。按技术：。

The report provides the bifurcation of synthetic biology market into five segments on the basis of technology: PCR (Polymerase Chain Reaction), NGS (Next Generation Sequencing), Genome Editing, Bioprocessing and Others. The PCR segment held the highest market share in 2022.

该报告根据技术将合成生物学市场分为五个部分：PCR（聚合酶链反应），NGS（下一代测序），基因组编辑，生物加工等。2022年，PCR市场份额最高。

Polymerase Chain Reaction (PCR) has emerged as one of the key technologies for the detection and analysis of specific gene sequences. The real-time PCR assays provide high sensitivity and specificity, making it the go-to method for numerous genomic studies based on PCR. This technique is widely used in various areas such as forensic research, DNA cloning, molecular diagnostics, and genomics..

聚合酶链反应（PCR）已成为检测和分析特定基因序列的关键技术之一。实时PCR分析提供了高灵敏度和特异性，使其成为许多基于PCR的基因组研究的首选方法。该技术广泛应用于法医研究，DNA克隆，分子诊断和基因组学等各个领域。。

Genome editing segment is expected to grow at the fastest CAGR during the forecasted period. Genome editing technologies, particularly CRISPR-Cas9, have ushered in a new era of precision in genetic engineering. CRISPR-Cas9 enables targeted modifications of DNA sequences with unparalleled accuracy. This technology holds immense potential for applications in agriculture, medicine, and biotechnology.By Application:.

在预测期间，基因组编辑片段预计将以最快的复合年增长率增长。基因组编辑技术，特别是CRISPR-Cas9，开创了基因工程精确性的新时代。CRISPR-Cas9能够以无与伦比的准确性对DNA序列进行靶向修饰。这项技术在农业，医学和生物技术中具有巨大的应用潜力。按应用程序：。

The report provides the bifurcation of synthetic biology market into two segments on the basis of application: Healthcare, and Non Healthcare. Healthcare segment dominated the market in 2022.

该报告根据应用将合成生物学市场分为两个部分：医疗保健和非医疗保健。2022年，医疗保健部门主导了市场。

Diagnostic based on synthetic biology provides a highly specific, sensitive, real-time, and non-invasive process for detecting infectious agents, cancer cells, and therapeutics. Researchers employ rational engineering techniques to design novel bio-sensing systems that are dynamic and constituted of a processor, sensor, and reporter..

基于合成生物学的诊断为检测感染因子，癌细胞和治疗剂提供了高度特异性，灵敏，实时和非侵入性的过程。研究人员采用合理的工程技术来设计新型生物传感系统，这些系统是动态的，由处理器、传感器和报告器组成。。

The segment is also propelled by an increase in neurological disorders such as multiple sclerosis. Non healthcare segment is expected to grow at the fastest CAGR during the forecasted period, driven by the increasing emphasis on sustainable practices and the urgent need to address environmental challenges.

多发性硬化症等神经系统疾病的增加也推动了这一领域的发展。在预测期内，非医疗保健部门预计将以最快的复合年增长率增长，这是由于越来越重视可持续实践以及迫切需要应对环境挑战。

Companies and industries are turning to synthetic biology to develop eco-friendly solutions, driving innovation and growth in these non-healthcare applications.By End User:.

公司和行业正在转向合成生物学来开发环保解决方案，推动这些非医疗保健应用的创新和增长。按最终用户：。

The report identifies three segments on the basis of end users: Biotech and Pharmaceutical Companies, Academic and Research Institutes, and Others.

该报告根据最终用户确定了三个部分：生物技术和制药公司、学术和研究机构以及其他部门。

Academic and research institutes segment is expected to grow at the fastest CAGR during the forecasted period. The adoption of synthetic biology in this segment is likely to be driven by the continuous quest for scientific knowledge and the need to develop innovative solutions. The R&D sector is considered to be capital-intensive owing to long development periods and approval cycles.By Region:.

在预测期内，学术和研究机构部门预计将以最快的复合年增长率增长。在这一部分中采用合成生物学可能是由于对科学知识的不断追求和开发创新解决方案的需要。由于开发周期长和审批周期长，研发部门被认为是资本密集型部门。按地区：。

North America accounted for the largest share in the global synthetic biology market in 2022. North America holds a crucial position in the global synthetic biology market, boasting a diverse ecosystem that includes numerous pharmaceutical and biotechnology giants, esteemed academic institutions, and state-of-the-art research centers..

2022年，北美在全球合成生物学市场上占据最大份额。北美在全球合成生物学市场上占据着至关重要的地位，拥有多样化的生态系统，其中包括众多制药和生物技术巨头、备受尊敬的学术机构和最先进的研究中心。。

This collective environment significantly fuels the demand for synthetic biology solutions. Leading the world in biotech research, North America stands out with substantial investments in research and development (R&D), creating a substantial appetite for products related to synthetic biology. The Asia Pacific region is expected to be the fastest-growing market.

这种集体环境极大地促进了对合成生物学解决方案的需求。北美在生物技术研究方面处于世界领先地位，在研究和开发（R＆D）方面进行了大量投资，对合成生物学相关产品产生了巨大的需求。预计亚太地区将是增长最快的市场。

The Asia-Pacific region has experienced a notable surge in its biotechnology and life sciences sector, with countries such as China, India, Japan, and South Korea making substantial investments specifically in the field of synthetic biology..

亚太地区的生物技术和生命科学部门经历了显著的激增，中国、印度、日本和韩国等国家专门在合成生物学领域进行了大量投资。。

This increased focus on research and development extends particularly to areas like genomics, personalized medicine, and genetic research. The growing scientific activity in these domains has naturally led to a heightened demand for synthetic biology techniques, crucial for precisely assembling DNA strands in cutting-edge research endeavors. Impact Analysis of COVID-19 and Way Forward:The COVID-19 pandemic had a multifaceted impact on the synthetic biology market.

这种对研究和开发的日益关注特别延伸到基因组学，个性化医学和基因研究等领域。这些领域日益增长的科学活动自然导致对合成生物学技术的需求增加，这对于在尖端研究工作中精确组装DNA链至关重要。新型冠状病毒肺炎的影响分析和前进方向：新型冠状病毒肺炎对合成生物学市场产生了多方面的影响。

Initially, disruptions in global supply chains and research laboratory closures caused delays in research projects, leading to a temporary setback in demand for synthetic biology services and products. Many research and development activities were delayed or put on hold, affecting the progress of projects and product launches..

最初，全球供应链中断和研究实验室关闭导致研究项目延误，导致合成生物学服务和产品需求暂时受挫。许多研发活动被推迟或暂停，影响了项目和产品发布的进度。。

However, the pandemic also highlighted the importance of synthetic biology in addressing global health challenges. The urgent need for innovative solutions, including vaccine development and biomanufacturing processes, underscored the resilience and adaptability of the synthetic biology industry.

然而，这一流行病也突出了合成生物学在应对全球健康挑战方面的重要性。迫切需要创新的解决方案，包括疫苗开发和生物制造过程，突出了合成生物学行业的弹性和适应性。

Competitive Landscape:

竞争格局：

Partnerships in the SynBio (Synthetic Biology) industry play a crucial role in fostering innovation, accelerating research and development, and addressing the complex challenges inherent in this rapidly evolving field. The SynBio industry is currently in its early growth stage, leading to significant fragmentation among small and medium-sized companies, each with proprietary technologies..

合成生物（合成生物学）行业的合作伙伴关系在促进创新、加速研究和开发以及应对这一快速发展领域固有的复杂挑战方面发挥着至关重要的作用。合成生物行业目前正处于早期增长阶段，导致中小型公司之间的严重分裂，每个公司都拥有专有技术。。

This fragmentation is expected due to rapid technological innovation, enabling smaller companies to enter diverse SynBio markets with niche solutions. In this landscape, larger companies often utilize 'tuck-in acquisitions' to enhance their position by seamlessly integrating the technology or product of a smaller company into their existing operations..

这种分裂预计是由于快速的技术创新，使较小的公司能够通过利基解决方案进入不同的合成市场。在这种情况下，较大的公司通常利用“插入式收购”，通过将较小公司的技术或产品无缝集成到其现有运营中来提高其地位。。

This strategy allows them to fill specific gaps, complement capabilities, and gain a competitive advantage, expanding market reach or accelerating product development. Ginkgo Bioworks, for instance, has been actively employing tuck-in acquisitions to address technology gaps, particularly in the field of biotherapeutics..

这一战略使他们能够填补特定的空白，补充能力，获得竞争优势，扩大市场覆盖面或加速产品开发。例如，银杏生物工厂（Ginkgo Bioworks）一直在积极采用收购方式来弥补技术差距，特别是在生物治疗领域。。

Market Dynamics

市场动态

Growth Drivers

增长驱动因素

Rising Prevalence of Genetic Disorders

遗传疾病患病率上升

Increasing Investments in Synthetic Biology Industry

增加对合成生物产业的投资

Evolving Landscape of the Synthetic Biology Industry

合成生物产业的发展前景

Advancements in DNA Sequencing and Gene Synthesis Technologies

DNA测序和基因合成技术的进展

Rising Demand for Bio-based Products

对生物基产品的需求不断增长

Increase in Synthetic Drugs and Vaccines

合成药物和疫苗的增加

Improvements in Diagnosis and Treatment

诊断和治疗的改进

Challenges

挑战

Stringent Government Regulations and Guidelines

严格的政府法规和指导方针

Ethical Considerations Regarding DNA Synthesis Regulation

关于DNA合成调控的伦理考虑

Complexity of Biological Systems

生物系统的复杂性

Market Trends

市场趋势

Increasing Utilization of AI in Synthetic Biology

人工智能在合成生物学中的应用

Expansion in Agriculture and Food Production

扩大农业和粮食生产

Technological Innovations

技术创新

Rising Potential of Synthetic Biology in Consumer Goods

合成生物学在消费品中的发展潜力

The key players of the global synthetic biology market are:

全球合成生物学市场的主要参与者包括：

Thermo Fisher Scientific Inc.

赛默飞世尔科技公司。

Twist Bioscience Corporation

Twist生物科学公司

Genscript Biotech Corporation

Genscript生物技术公司

Amyris, Inc.

股份有限公司Amyris。

Codexis, Inc.

Codexis公司。

Danaher Corporation (Integrated DNA Technologies)

Danaher Corporation（集成DNA技术）

Ginkgo Bioworks

银杏生物制品

Agilent Technologies, Inc

安捷伦科技有限公司

Telesis Bio, Inc.

Telesis生物公司。

Precigen, Inc

Precigen, Inc

For more information about this report visit https://www.researchandmarkets.com/r/rs632f

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/rs632f

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

关于ResearchAndMarkets.com ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。

Media Contact:

媒体联系人：

Research and MarketsLaura Wood, Senior Manager[email protected]

研究与市场高级经理Slaura Wood[受电子邮件保护]

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

对于E.S.T办公时间，请拨打+1-917-300-0470（对于美国）/CAN免费电话+1-800-526-8630（对于GMT办公时间），请拨打+353-1-416-8900

U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

U、 美国传真：646-607-1907传真（美国境外）：+353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

徽标：https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

来源研究和市场